🔎 Trials Near Me

Gara Jalqabaatti › Lymphoma B-Cell › Ohio › Cleveland

Qorannoo klinikaalii Lymphoma B-Cell Cleveland, OH keessatti

Qorannoo 9 Lymphoma B-Cell f Cleveland fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Namoota walitti qabaa jiraSadarkaa 1/2
  • University Hospitals Seidman Cancer Center, Cleveland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06343311

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Namoota walitti qabaa jiraSadarkaa 3
  • University Hospitals, Cleveland
  • Cleveland Clinic Foundation, Cleveland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06742996

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Namoota walitti qabaa jiraSadarkaa 1
  • Cleveland Clinic, Cleveland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07101328

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Namoota walitti qabaa jiraSadarkaa 1
  • Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, Cleveland
  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07225439

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

Namoota walitti qabaa jiraSadarkaa 1
  • Clinical Trial Site, Cleveland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT06393738

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 1/2
  • Cleveland Clinic, Cleveland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05826535

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Namoota walitti qabaa jiraSadarkaa 3
  • Cleveland Clinical Taussig Cancer Center, Cleveland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT07188558

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Rainbow Babies, Cleveland
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Mud-2024 · NCT05476770

Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
  • University Hospitals Seidman Cancer Center, Cleveland
  • Taussig Cancer Institute | Cleveland Clinic, Cleveland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Onk-2024 · NCT05312801

Qorannoo Lymphoma B-Cell magaalota biroo keessatti

Qorannoo biroo Cleveland keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.